fbpx

QQQ
+ 3.41
366.16
+ 0.92%
BTC/USD
+ 939.70
44529.23
+ 2.16%
DIA
+ 5.05
337.45
+ 1.47%
SPY
+ 5.28
432.58
+ 1.21%
TLT
-3.43
155.22
-2.26%
GLD
-1.88
167.30
-1.14%

Why Cassava Sciences Shares Are Moving Today

June 21, 2021 2:26 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Cassava Sciences Inc (NASDAQ:SAVA) shares are trading higher by 11.2% at $88.50 after the company highlighted clinical development progress and provided guidance on upcoming data releases for simufilam, the company's lead drug candidate to treat Alzheimer's disease.

Cassava Sciences is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.


Related Articles

B. Riley Says Alzheimer's Data From This Firm Has Renewed 'Investor Confidence'

B. Riley Says Alzheimer's Data From This Firm Has Renewed 'Investor Confidence'

B. Riley says yesterday's readout from a pre-planned 12-month treatment interim analysis of Cassava Sciences Inc's (NASDAQ: SAVA) simufilam trial data "reinvigorate" investor confidence.  read more
Cassava Sciences' Simufilam Data Shows Improved Cognition In Alzheimer's Disease

Cassava Sciences' Simufilam Data Shows Improved Cognition In Alzheimer's Disease

GameStop Continues To See Sky-High WallStreetBets Interest; AMC, BlackBerry, Alibaba, Palantir Are Other Top Trends

GameStop Continues To See Sky-High WallStreetBets Interest; AMC, BlackBerry, Alibaba, Palantir Are Other Top Trends

GameStop Corp. (NYSE: GME) continued to be the most-discussed stock on Reddit’s r/WallStreetBets forum as of Wednesday night, while AMC Entertainment Holdings Inc. read more
Cassava Sciences Receives FDA's Special Protocol Assessment For Alzheimer's Trials

Cassava Sciences Receives FDA's Special Protocol Assessment For Alzheimer's Trials